The Future is N-of-1 Personalized Health & Medicine
FON Consulting has recently pivoted its brand positioning to Personalized Medicine. Here’s why.
Integrative, functional, lifestyle, holistic, antiaging, precision, regenerative, allopathic… the names and nomenclature have become a blur. They overlap. They confuse. What unites these approaches is a shared focus on both the host (patient) and the underlying disease or pathology.
Each specialty aspires to put the patient at the center of their own health and medical journey… with an inexorable march toward personalized care—to address a challenging medical condition or optimize health in support of salutogenesis and true healthspan.
Each of us, in health and in illness, is an N-of-1—a study of one. Each host is different. Each condition or pathology is different. Each psyche is different. Each environment, diet, exposure to toxins, level of movement, level of stress, level of resilience is, well, different.
I posit that all of these ‘medical specialties’ fall into the larger bucket of personalized medicine. To wit:
FON THESIS
The future of health and medicine is preventive, personalized, and participatory, centered on each individual’s biology, pathology, and lifestyle. It integrates behavioral choices with advanced biomedical diagnostics and interventions for measurable impact.
Technology and AI are largely outpacing traditional clinical guidelines. Medicine is moving from one-size-fits-all population level approaches to truly individualized care. Personalized oncology illustrates this shift, using molecular and functional profiling, lifestyle-informed strategies, and advanced multiomic testing to guide both on- and off-label therapies. Integrative and functional medicine apply many of these same principles across wellness and disease, emphasizing patient-centered, evidence-based and informed interventions.
In a personalized medicine world, patient health and organizational financial success are inseparable—they must work together.
This is FON. For those who see health and medicine like us, let’s talk.
Glenn Sabin, founder of FON and author of n of 1, is a nationally recognized thought leader who positions health innovators, enterprises, and organizations for sustainable growth. Leveraging deep experience in media, strategy, marketing, and business development—and his own compelling cancer journey—he champions personalized medicine and the generation of real-world data and evidence to help define a new, accessible standard of care.
Read Glenn’s story.
